证券代码：300534 证券简称：陇神戎发 公告编号：2025-048 甘肃陇神戎发药业股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 一、会议召开和出席情况 （一）会议召开情况 （1）现场会议召开时间：2025 年 6 月 17 日下午 14:00 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为 互联网投票系统进行网络投票的时间为2025年6月17日9:15—15:00期间的任意 时间。 部门规章、规范性文件和《公司章程》的规定。 （二）会议出席情况 出席本次股东会现场会议和网络投票的股东及股东授权委托代表共 192 人， 代表股份 118,310,230 股，占公司总股本的 39.0019％。 二、议案审议表决情况 本次会议以现场投票和网络投票相结合的方式对以下议案进行了表决，表决 结果如下： 其中：出席现场会议的股东及股东授权委托代表共 4 人，代表股份数 议的股东共 188 人，代表股份数 4,250,920 股，占公司有表决权股份总数的 出席本次股东会现场会议和网络投票的中小股东及股东授权委托代表共 18 ...

新华财经上海6月17日电（记者魏雨田）今年以来，医药板块延续结构性行情热度，其中创新药赛道表 现尤为亮眼。财通基金医药基金经理骆莹的投资框架以"攻守平衡"为锚，在投资布局中构建"低估值底 仓 + 进攻性仓位"的双轮驱动策略。 针对创新药板块的持续狂热，骆莹在接受记者采访时表示，目前市场对创新药的想象空间有过度透支的 风险，虽具体触发时点难以预判，但风险规避或是更稳妥的策略。展望后市，骆莹持续看好中药与医药 设备板块的发展潜力，其中保健滋补类产品及心脑血管领域为其目前重点关注方向。 透支未来存估值风险 拥有上海交通大学生物医学工程本科与安泰金融硕士复合背景的骆莹，在医药投资领域已深耕十余年。 从卖方医药研究员，再到买方医药研究员，她完整经历了行业多轮周期更迭。丰富的职业经历塑造了她 独特的投资框架。 骆莹投资框架的核心逻辑是"估值是投资的锚"。她认为，透支未来增长的估值难以持续。当资产价格脱 离合理价值区间，离场时机将难以判断。因此，她始终坚持一个原则：一旦价格触及内在价值测算边 界，就果断退出。这种对估值的严谨把控，成为她投资决策的重要依据。 "这轮行情本质是PD-1类产品专利到期周期下，下一代免疫疗法崛起引 ...

晨 会 纪 要 [2025]第 108 号 主 题：对近期重要经济金融新闻、行业事件、公司公告等进行点评 时 间：2025 年 6 月 17 日 8:50-9:30 会议形式：腾讯会议 参会人员：曹旭特 朱毅 仇华 许雯 王攀 蒋栋 张德燕 轩鹏程 文正平 李杰 王文瑞 张智珑 郭怡萍 何超 李育文 李正威 别璐莎 邢维洁 王逸奇 孙菲 马丽明 贺钰偲 汪炜 聂孟依 顾华昊 整理记录：李正威 研究所今日晨会要点如下: 一、行业公司 1、中药行业（许雯） 核心要点： 市场表现：上周中药Ⅱ下跌0.32%，医药板块涨跌互现，中药表现相对较弱 根据wind数据，上周（2025.06.08-2025.06.14）医药生物报收7895.79点，上涨1.4%；中 药Ⅱ报收6410.24点，下跌0.32%；化学制药报收12686.19点，上涨3.53%；生物制品报收6212.51 点，上涨0.33%；医药商业报收5099.4点，下跌0.83%；医疗器械报收6147.18点，下跌0.52%； 医疗服务报收5403.37点，上涨2.42%。医药二级子板块涨跌互现，化学制药表现最好，中药 表现相对较弱。 根据wind数据，上周中药 ...

Core Insights - Beijing Tongrentang's Shengmai Drink participated as the official health partner in the "Symphony Youth" music festival, aiming to engage with university students and promote traditional Chinese medicine in a modern context [1][8] - The event featured interactive areas like the "Vitality Diagnosis Research Institute" and "Extreme Challenge Training Camp," allowing students to experience the health benefits of Shengmai Drink through creative engagement [3][8] - The festival coincided with Father's Day, enhancing emotional connections through a collective performance of "Father's Prose Poem," which elevated the event's atmosphere [5][10] Company and Industry Summary - Beijing Tongrentang Shengmai Drink's "Vitality Supply Station" became a focal point at the festival, attracting a large number of students eager to learn about health and traditional Chinese medicine [5][6] - The company effectively combined professional Chinese medicine consultations with a vibrant music festival, breaking down barriers between traditional culture and younger audiences [8][12] - The event highlighted the brand's commitment to innovation and cultural transmission, showcasing its role in the creative transformation and development of traditional Chinese medicine in contemporary society [8][12]

Core Viewpoint - The annual shareholder meeting of Beijing Tongrentang Technology Development Co., Ltd. highlighted the company's steady growth and future strategic planning despite a complex market environment [1][2]. Group 1: Company Performance - The company maintained a stable development trajectory over the past year by deepening internal management reforms, optimizing production processes, and enhancing product quality and service levels [1]. - The company increased its investment in research and development to drive product innovation and meet the diverse needs of the market [1]. Group 2: Shareholder Engagement - During the interactive session, shareholders actively discussed the company's performance, market presence, and long-term development strategies, providing valuable feedback and suggestions for future growth [2]. - The new management team demonstrated an open and positive attitude, carefully listening to shareholder concerns and responding sincerely, which strengthened shareholder trust in the management [2]. Group 3: Shareholder Appreciation - Following the meeting, the company organized a health consultation and a product showcase for attending shareholders, where traditional Chinese medicine experts provided health advice and cultural knowledge [4]. - The product showcase featured a variety of high-quality products, creating a warm and harmonious atmosphere for the event [4]. Group 4: Future Outlook - The company aims to use this meeting as a new starting point to remember its original intentions and strive for high-quality development [6].

Core Viewpoint - The recognition of Li Ning as a representative inheritor of the traditional production technique of Tongrentang's Xihuangwan signifies the importance of preserving and innovating traditional Chinese medicine practices in Beijing's cultural heritage [1][15]. Group 1: Company Overview - Tongrentang Technology Development Co., Ltd. has been involved in the traditional production of Chinese medicine, specifically Xihuangwan, which is a significant product in their portfolio [1]. - The company emphasizes the integration of traditional craftsmanship with modern techniques to enhance production efficiency and product quality [11]. Group 2: Skills and Techniques - Li Ning has mastered various intricate techniques in the production of Xihuangwan, including precise mixing of medicinal powders, careful control of ingredient ratios, and quality assurance through visual and tactile assessments [4][7]. - The production process involves multiple steps such as mixing, screening, drying, and coating, all of which require a high level of skill and attention to detail [5][9]. Group 3: Innovation and Adaptation - Li Ning has adapted the production techniques to meet modern standards, including the introduction of methods to ensure the stability of key components like bilirubin in the final product [9]. - The company has responded to increasing market demand by optimizing production processes, which has significantly improved yield rates and ensured a stable supply of Xihuangwan [11]. Group 4: Cultural Heritage and Education - Li Ning has taken on the role of mentor, establishing a skills master studio to pass on the traditional techniques to apprentices, thereby ensuring the continuity of this cultural heritage [13]. - The company actively participates in cultural events to promote traditional Chinese medicine and its values, enhancing public awareness and appreciation of its heritage [15].

Group 1 - The actual controller of Jichuan Pharmaceutical, Cao Longxiang, is transferring shares to his son, Cao Fei, which triggers a mandatory tender offer for the company [1][2] - Cao Fei will acquire 351 million shares, representing 38.06% of the total issued shares, with a maximum transaction value of 9.448 billion yuan [1][2] - Following the share transfer, Cao Fei's stake in Jichuan Holdings will increase to 60%, allowing him to indirectly control 517 million shares of Jichuan Pharmaceutical, exceeding the 30% threshold for a mandatory tender offer [2] Group 2 - Jichuan Pharmaceutical is facing significant pressure, with revenue and net profit declining for four consecutive quarters due to price cuts from centralized procurement [4] - In 2024, the company expects to achieve revenue of 8.017 billion yuan, a year-on-year decrease of 16.96%, and a net profit of 2.532 billion yuan, down 10.32% [4] - The company's sales expenses are high at 2.954 billion yuan, accounting for 36.85% of total revenue, while R&D expenses are only 445 million yuan, representing 5.55% of total revenue [4]

迈入年中，上市公司半年度业绩表现备受市场关注。 统计数据显示，截至6月16日收盘，共计8家公司率先预告了公司今年上半年的经营表现。 从预测类型来看，4家公司预计"续盈"，3家公司预计"略增"；1家公司预计"略减"。 | 证券代码 | 名称 | 预告日期 ↓ 顿警类型 预警摘要 | | | --- | --- | --- | --- | | 301590.SZ | 优优绿能 | 2025-05-15 续盈 | 净利润:约1.18亿元~1.42亿元,增长-15.19%~2.05% | | 301595.SZ | 太力科技 | 2025-05-16 续盈 | 净利润:约4524万元~5542万元,增长-10.71%~7.04% | | 603382.SH | : C海阳 | :2025-05-23 续盈 | 净利润:约7600万元~8600万元,增长-2.05%~10.83% | | 688775.SH | ! C影石 | 2025-05-22 续盈 | 净利润:约4.94亿元~5.83亿元,增长-4.65%~12.49% | | 001390.SZ | :古麒绒材 | :2025-05-09 : 略增 | 净利润 ...

Wind统计数据显示，截至6月16日收盘，共计8家公司率先预告了公司今年上半年的经营表现。 从预测类型来看，4家公司预计"续盈"，3家公司预计"略增"；1家公司预计"略减"。 | 证券代码 | 名称 | 预告日期 | ↓ 预警类型 · 预警摘要 | | | --- | --- | --- | --- | --- | | 301590.SZ | ! 优优绿能 | 2025-05-15 | 绿猫 | 净利润:约1.18亿元~1.42亿元,增长-15.19% ~2.05% | | 301595.SZ | 太力科技 | 2025-05-16 | 续篇 | 净利润:约4524万元~5542万元,增长-10.71%~7.04% | | 603382.SH | : C海阳 | : 2025-05-23 | 续营 | 净利润:约7600万元~8600万元,增长-2.05%~10.83% | | 688775.SH | ! C影石 | 2025-05-22 | 续营 | 净利润:约4.94亿元~5.83亿元,增长-4.65%~12.49% | | 001390.SZ | :古麒绒材 | 2025-05-09 | : 略信 | ...

Market Overview - Major A-share indices experienced slight gains, with the Shanghai Composite Index rising by 0.35% to 3388 points, the Shenzhen Component Index increasing by 0.41%, and the ChiNext Index up by 0.66% [1][2]. Trading Volume - The total trading volume for the day reached 1.24 trillion yuan, a decrease of 260.4 billion yuan compared to the previous trading day, with over 3500 stocks rising across the market [2]. Sector Performance Strong Performers - The stablecoin and digital currency sectors saw significant gains, with multiple stocks hitting the daily limit, including Tianyang Technology and Hailian Jinhui [2][4]. - The wind power equipment sector also performed well, with Yunda Co. hitting the daily limit with a 20% increase [2][7]. - The gaming sector showed strong performance, with Xinghui Entertainment rising over 14% [2][8]. - Oil and gas stocks surged, with Tongyuan Petroleum and Keli Co. both hitting the daily limit [2][9]. - The film and television sector strengthened, with Guangxin Media hitting the daily limit and other companies like Bona Film Group and Huayi Brothers also seeing gains [2][10]. Weak Performers - The precious metals and gold sectors experienced declines, with Xiaocheng Technology leading the drop [3][11]. - The aerospace sector also fell, with multiple stocks dropping over 3% [3]. - The traditional Chinese medicine sector weakened, with Kanghui Pharmaceutical hitting the daily limit down [3][13]. - The automotive sector saw declines, with Great Wall Motors dropping over 2% [3][12]. Notable Stocks - Tianyang Technology rose by 20% to 22.68 yuan, while Sifang Jichuang increased by nearly 20% [5][6]. - Yunda Co. also saw a 20% increase, reaching 12.72 yuan [7]. - Xinghui Entertainment rose by 14.07% to 5.19 yuan [8]. - Tongyuan Petroleum increased by 19.96% to 6.07 yuan [9]. - Guangxin Media rose by 19.98% to 22.10 yuan [10]. Future Outlook - CITIC Securities suggests focusing on the supply chain for computing power, including AI servers, PCB, ASIC chips, and related components, while monitoring application segments such as AI glasses and toys [13].